Abstract
AIM: The "2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia" retires and replaces the "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." METHODS: A comprehensive literature search was conducted from October 2024 to December 2024 to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).
Author supplied keywords
- ACC/AHA clinical practice guideline
- HDL
- LDL
- anticholesteremic agents
- atherosclerosis
- atherosclerotic disease
- cardiovascular disease
- cardiovascular diseases
- cholesterol
- drug interactions
- dyslipidemia(s)
- hydroxymethylglutaryl-CoA reductase inhibitors
- hypercholesterolemia
- hyperlipid(a)emia/s
- hyperlipoproteinemia type II
- hypertriglyceridemia
- hypolipidemic agents
- lipids
- lipoprotein(a)
- primary prevention
- risk adjustment
- risk assessment
- risk factors
- simvastatin
- statin(s)
- triglycerides
Cite
CITATION STYLE
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., … Wilkins, J. T. (2026). 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 87(19), 2624–2757. https://doi.org/10.1016/j.jacc.2025.11.016
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
